Vitalhub (TSE:VHI) Stock Gets Price Target Reduction from Scotia

Vitalhub (TSE:VHI – Free Report) had its price objective lowered by Scotia from C$12.00 to C$9.00 in a research note published on Monday,BayStreet reports. The brokerage currently has a sector outperform rating on the stock.

Several other equities research analysts have also weighed in on VHI. Canaccord Genuity Group set a C$15.00 price objective on Vitalhub and gave the stock a “buy” rating in a report on Friday, August 28th. ATB Cormark Capital Markets dropped their price objective on shares of Vitalhub from C$12.00 to C$10.25 and set an “outperform” rating on the stock in a report on Monday. Finally, TD dropped their price objective on shares of Vitalhub from C$13.00 to C$9.50 and set a “buy” rating on the stock in a report on Monday. Eight research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of C$10.86.

Read Our Latest Stock Report on Vitalhub

Vitalhub Price Performance

TSE:VHI opened at C$6.66 on Monday. The business has a fifty day simple moving average of C$7.49 and a two-hundred day simple moving average of C$7.55. Vitalhub has a 1 year low of C$6.46 and a 1 year high of C$9.77. The company has a market capitalization of C$421.84 million, a P/E ratio of 55.50, a P/E/G ratio of 1.18 and a beta of 1.37.

Vitalhub (TSE:VHI – Get Free Report) last issued its quarterly earnings results on Thursday, November 12th. The company reported C$0.04 EPS for the quarter. Vitalhub had a return on equity of 4.03% and a net margin of 8.63%. The firm had revenue of C$31.91 million for the quarter. As a group, analysts anticipate that Vitalhub will post 0.23 earnings per share for the current year.

Vitalhub News Summary

Investors following VHI have been watching these news items:

  • Positive Sentiment: Canaccord Genuity and Scotiabank are reported as maintaining or issuing Buy recommendations, indicating that both see potential upside despite the broader target reductions. Canaccord Genuity Buy report Scotiabank Buy report
  • Negative Sentiment: Multiple firms—including ATB Cormark, Canaccord, Stifel Nicolaus, Raymond James and National Bank Financial—cut their price targets for Vitalhub. Scotia and TD also issued more pessimistic price forecasts. Target cuts can weigh on sentiment by implying less expected upside, even when an analyst’s rating remains Buy. ATB Cormark target cut Analyst target cuts and fair value
  • Negative Sentiment: Royal Bank of Canada downgraded Vitalhub from “Moderate Buy” to “Hold,” signaling a less favorable view of the shares. RBC recommendation

About Vitalhub

(Get Free Report)

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.

See Also

Analyst Recommendations for Vitalhub (TSE:VHI)

Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.